Designing better antibody drugs with artificial intelligence Research ETH Zurich Machine learning methods help to optimise the development of antibody drugs. This leads to active substances with improved properties, also with regard to tolerability in the body. Previous 2 3 4 5 6 7 8 9 Page 9 of 9
